India’s IDSP Reports Surge in Zoonotic Diseases and Highlights DBT‑Led Vaccine Initiatives (2022‑2026)
The IDSP has recorded a sharp rise in several zoonotic infections across states. In response, the Ministry of Science & Technology, through the Department of Biotechnology (DBT) and its research network, is accelerating vaccine development for both human and animal diseases.
Key Developments (2022‑2026)
- Surveillance data: Cases of KFD rose from 54 in 2022 to 373 in 2024 before falling to 80 in early 2026; leptospirosis cases hovered around 10‑19 thousand annually; scrub typhus exceeded 70,000 cases in 2024.
- Vaccine research: Multiple BRIC institutes are developing next‑generation vaccines, including DNA, circular RNA (circRNA) and monoclonal antibodies against rabies, dengue, Zika, Nipah and Japanese encephalitis.
- Collaborative frameworks: A five‑year partnership between DBT, BIRAC and the CEPI aims to boost India’s vaccine‑development capacity.
- Funding mechanisms: The Biotechnology Ignition Grant has backed start‑ups working on DNA‑based rabies vaccines for stray dogs, pan‑influenza vaccines, mRNA dengue vaccines and malaria therapeutics.
Important Facts & Figures
According to Annexure‑I (IDSP‑IHIP portal), the cumulative cases from 2022‑2026 are:
- KFD: 727 cases
- Leptospirosis: 64,784 cases
- Scrub Typhus: 255,563 cases
Annexure‑II records outbreak‑specific numbers for West Nile Fever, Nipah, CCHF and Human Rabies across several states, indicating a geographic spread beyond traditional hotspots.
UPSC Relevance
These developments intersect with multiple GS papers:
- GS‑2 (Polity): Role of ministries, inter‑ministerial coordination and parliamentary oversight in health emergencies.
- GS‑3 (Economy & Health): Public‑health financing, vaccine R&D ecosystem, and the economic impact of zoonotic outbreaks.
- GS‑4 (Ethics & Governance): One‑Health approach, ethical considerations in animal‑vaccination programmes, and patent filing strategies.
Way Forward
To translate surveillance into containment, aspirants should note the following policy recommendations:
- Strengthen One‑Health coordination among health, wildlife, agriculture and urban planning ministries.
- Scale up diagnostic capacity in remote districts to sustain the upward trend in case detection.
- Accelerate clinical trials of BRIC‑developed vaccines, ensuring indigenous technology reduces import dependence.
- Expand BIG and CEPI funding to cover post‑licensure surveillance and cold‑chain logistics for rural immunisation.
- Incorporate zoonotic disease modules in medical and veterinary curricula to build a skilled workforce.
By monitoring the evolving data and supporting home‑grown vaccine pipelines, India can mitigate the health‑economic burden of zoonoses and showcase a robust public‑health model for the UPSC syllabus.